Explore more publications!

Political Press Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Political Press Watch.

Press releases published on February 26, 2026

Diversified to Acquire Complementary, High-Quality, Low-Decline Producing Assets
Rocket Lab Secures Latest Multi-Launch Contract with BlackSky for 4x Dedicated Electron Missions
Rocket Lab Establishes New Precision Machining Complex, Expands Manufacturing Footprint with Acquisition of Precision Components Ltd
Rocket Lab Introduces Advanced Silicon Solar Arrays To Power Space-Based Data Centers
Rocket Lab Completes Spacecraft Commissioning for NASA’s ESCAPADE Mars Mission
Rocket Lab Acquires Optical Support, Inc., Strengthening National Security Payload Capability
Rocket Lab Announces Fourth Quarter and Full Year 2025 Financial Results, Posts Record Quarterly Revenue of $180M, Record Annual Revenue of $602M, Delivering Annual Growth of 38% and Growing Backlog 73% Year-on-Year to $1.85B
Bridger Aerospace Announces Schedule for its Fourth Quarter 2025 Earnings Release and Conference Call
National CACFP Association Announces Speakers for 40th Annual National Child Nutrition Conference
Billboard Launches Maad's Bid for NC District 7
SBM Offshore starts EUR227 million share repurchase following completion of the 2025 program
Appointment of David Clarke  As New Director of Vallourec
DAVID CLARKE NOUVEL ADMINSTRATEUR DE VALLOUREC
Transaction in Own Shares
GENFIT : Information financière du quatrième trimestre 2025 et point sur les activités de la Société     
OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer
GENFIT Reports Fourth Quarter 2025 Financial Information and Provides a Corporate Update   
OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indépendant de Surveillance des Données (IDMC) pour l’essai pivot de Phase 3 ARTEMIA évaluant Tedopi® dans le cancer du poumon non à petites cellules
Bonduelle - 2025-2026 HY1 sales and financial results - The Bonduelle Group demonstrates its resilience in a particulary demanding environment
Bonduelle - Chiffre d'affaires et résultats du 1er semestre 2025-2026 - Le Groupe Bonduelle démontre sa résilience dans un contexte particulièrement exigeant

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions